Session Chair Profile
Chief Business Officer VP, Market Development Clinical Genomics and Bioinformatics, QIAGEN
Sean works with broad range of customer, partners and collaborators in the development of genomics-guided precision medicine programs and capabilities. In this role, Sean is responsible for QIAGEN’s Clinical Genomics product portfolio offering serving the clinical decision support needs of molecular diagnostics and molecular pathology testing laboratories and healthcare provider networks globally whom are implementing genomics-based precision medicine programs and require expertise in dry lab capabilities including test interpretation and reporting. Sean led the development of QIAGEN’s recently commercialized Clinical Insight clinical decision support platform, an instrument, assay and pipeline agnostic test interpretation and reporting system that enables clinical testing labs to develop broad test menus and scale the analysis, interpretation and reporting of tests and to improve the insightfulness and action-ability of reporting to ordering physicians. Prior to QIAGEN, developed and managed Ingenuity’s marketing, sales and support operations as SVP, Global Commercial Operations and SVP, Corporate Development for Ingenuity Systems.
Session Abstract – PMWC 2019 Silicon Valley
Session Synopsis: Genomics-guided precision medicine has become an integral component of patient stratification for treatment decision support of cancer and other diseases, including rare diseases. Yet genomics data integration with clinical data, such as outcomes data, and real-world evidence from disparate healthcare data systems still remains a challenge. This panel will discuss recent advancements, needs, and integration challenges to develop real-world evidence data assets in support of treatment decisions, clinical trial protocol design, and other clinical and research applications.